Status:

RECRUITING

Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse

Lead Sponsor:

University Hospital, Lille

Conditions:

Nitrous Oxide Abuse

Eligibility:

All Genders

14-65 years

Brief Summary

There is a toxicity linked to the chronic use of nitrous oxide, leading to neurological disorders such as combined sclerosis of the spinal cord. One thus frequently observes patients presenting disord...

Eligibility Criteria

Inclusion Criteria:

  • A current or former recreational nitrous oxide user defined
  • With associated clinical signs (group 1)
  • Without associated clinical signs (group 2)
  • With or without clinico-biological sequelae associated with use
  • Consenting to the conduct of the study
  • Socially insured

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • Never used nitrous oxide or stopped using it more than 6 months ago
  • Lack of social security coverage
  • Not willing to participate in the entire study

Key Trial Info

Start Date :

January 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 30 2025

Estimated Enrollment :

356 Patients enrolled

Trial Details

Trial ID

NCT05540561

Start Date

January 30 2023

End Date

January 30 2025

Last Update

October 26 2024

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

BETHUNE

Béthune, France

2

Boulogne Sur Mer

Boulogne-sur-Mer, France

3

CALAIS

Calais, France

4

Lens

Lens, France

Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse | DecenTrialz